Recurrent Amplification of the Osmotic Stress Transcription Factor

Adrenocortical carcinoma NFAT5 Osmotic Stress and SLC5A3

Journal

Journal of the Endocrine Society
ISSN: 2472-1972
Titre abrégé: J Endocr Soc
Pays: United States
ID NLM: 101697997

Informations de publication

Date de publication:
01 Jul 2020
Historique:
received: 31 03 2020
accepted: 20 05 2020
entrez: 27 6 2020
pubmed: 27 6 2020
medline: 27 6 2020
Statut: epublish

Résumé

Tumorigenesis requires mitigation of osmotic stress and the transcription factor nuclear factor of activated T cells 5 (NFAT5) coordinates this response by inducing transcellular transport of ions and osmolytes. NFAT5 modulates in vitro behavior in several cancer types, but a potential role of NFAT5 in adrenocortical carcinoma (ACC) has not been studied. A discovery cohort of 28 ACCs was selected for analysis. Coverage depth analysis of whole-exome sequencing reads assessed

Identifiants

pubmed: 32587934
doi: 10.1210/jendso/bvaa060
pii: bvaa060
pmc: PMC7304660
doi:

Types de publication

Journal Article

Langues

eng

Pagination

bvaa060

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© Endocrine Society 2020.

Références

Am J Physiol Cell Physiol. 2011 May;300(5):C1155-63
pubmed: 21289293
Lancet Oncol. 2015 Apr;16(4):426-35
pubmed: 25795408
N Engl J Med. 2007 Jun 7;356(23):2372-80
pubmed: 17554118
Surgery. 2016 Jan;159(1):250-7
pubmed: 26454676
Mol Cell. 2010 Dec 10;40(5):841-9
pubmed: 21109473
Cell Commun Signal. 2018 Jun 8;16(1):27
pubmed: 29884238
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2538-42
pubmed: 10051678
Physiol Rev. 2007 Oct;87(4):1441-74
pubmed: 17928589
Cell Death Dis. 2019 Dec 11;10(12):948
pubmed: 31827081
Front Physiol. 2014 Aug 08;5:293
pubmed: 25152734
Nat Rev Endocrinol. 2019 Sep;15(9):548-560
pubmed: 31147626
N Engl J Med. 2012 Jun 7;366(23):2189-97
pubmed: 22551107
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3566-3573
pubmed: 29982685
Nat Genet. 2014 Jun;46(6):607-12
pubmed: 24747642
Science. 2011 Feb 11;331(6018):768-72
pubmed: 21311022
Front Mol Neurosci. 2017 Sep 21;10:301
pubmed: 28983240
Nat Cell Biol. 2002 Jul;4(7):540-4
pubmed: 12080349
J Oncol. 2012;2012:234726
pubmed: 23125857
J Clin Endocrinol Metab. 2015 Mar;100(3):E493-502
pubmed: 25490274
Fertil Steril. 2011 Jun;95(7):2383-7
pubmed: 21496801
Biochem Biophys Res Commun. 2015 Sep 25;465(3):644-9
pubmed: 26299924
Nat Genet. 2013 Sep;45(9):1050-4
pubmed: 23913001
Physiol Genomics. 2016 Apr;48(4):290-305
pubmed: 26757802
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1358-1365
pubmed: 28324035
Am J Physiol Renal Physiol. 2000 Jun;278(6):F1006-12
pubmed: 10836989
Biophys J. 2015 Oct 6;109(7):1334-7
pubmed: 26445434
J Clin Med Res. 2018 Aug;10(8):636-640
pubmed: 29977421
Br J Cancer. 2013 Mar 5;108(4):826-30
pubmed: 23412108
Exp Clin Endocrinol Diabetes. 2019 Feb;127(2-03):109-116
pubmed: 30469158
Cancer Cell. 2016 Aug 8;30(2):363
pubmed: 27505681
Ann Surg Oncol. 2010 Jan;17(1):263-70
pubmed: 19851811
Am J Physiol Renal Physiol. 2005 Oct;289(4):F803-7
pubmed: 15900024
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Ann Surg Oncol. 2016 Jan;23(1):126-33
pubmed: 26282907
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Surgery. 2016 Jan;159(1):296-301
pubmed: 26453132
Ann Surg Oncol. 2018 Nov;25(12):3453-3459
pubmed: 30218246
Cancer Sci. 2019 Aug;110(8):2337-2347
pubmed: 31120184
J Membr Biol. 1995 Jan;143(2):103-13
pubmed: 7537337

Auteurs

Taylor C Brown (TC)

Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.

Norman G Nicolson (NG)

Department of Surgery & Yale Endocrine Neoplasia Laboratory, Yale University School of Medicine, New Haven, Connecticut.

Jianliang Man (J)

Department of Surgery & Yale Endocrine Neoplasia Laboratory, Yale University School of Medicine, New Haven, Connecticut.

Courtney E Gibson (CE)

Department of Surgery & Yale Endocrine Neoplasia Laboratory, Yale University School of Medicine, New Haven, Connecticut.

Adam Stenman (A)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

C Christofer Juhlin (CC)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.

Reju Korah (R)

Department of Surgery & Yale Endocrine Neoplasia Laboratory, Yale University School of Medicine, New Haven, Connecticut.

Tobias Carling (T)

Department of Surgery & Yale Endocrine Neoplasia Laboratory, Yale University School of Medicine, New Haven, Connecticut.

Classifications MeSH